ROLE OF TUMOR NECROSIS FACTOR IN MACROPHAGE ACTIVATION AND TUMORICIDAL ACTIVITY
- 1 October 1988
- journal article
- research article
- Vol. 48 (19) , 5427-5432
Abstract
Tumor necrosis factor (TNF)-sensitive (LM) and -insensitive (P815) target cell lines were used to examine the role of TNF in both the activation and lytic phases of macrophage-mediated lysis. LM cells were lysed spontaneously by thioglycolate-elicited macrophages in an 18-h assay (media or activating agents added with targets) or 36-h assay (macrophages cultured with media or activating agents for 18 h, washed, and targets added for a subsequent 18 h). In contrast, P815 cell were lysed only in the 36-h assay be macrophages exposed to appropriate activation signals. Using antibody to murine TNF, it was shown that lysis of LM cells but not P815 cells was TNF mediated. The addition of lipopolysaccharide (LPS) to the 18-h assay resulted in augmented LM killing. This was probably due to the fact that LPS stimulates macrophages to produce TNF. Conversely, when macrophages were pretreated with LPS for 18 h, washed, and assessed for lytic activity during the subsequent 18 h, lysis of LM cells was reduced relative to the endogenous level. Although macrophage lysis of P815 was not mediated by TNF, the addition of TNF to macrophage activation cultures facilitated LPS triggering of cytolytic activity against P815. Similarly, the addition of TNF to the activation cultures partially prevented the LPS-induced reduction in macrophage-mediated LM cell lysis. Taken together, these data suggest that TNF may act as an autocrine signal during macrophage activation, in addition to being directly lytic to a select number of sensitive target cell lines.This publication has 19 references indexed in Scilit:
- Tumor necrosis factor is an important mediator of tumor cell killing by human monocytes.The Journal of Immunology, 1987
- COMBINATION IMMUNOTHERAPY OF CANCER IN A MOUSE MODEL - SYNERGISM BETWEEN TUMOR-NECROSIS-FACTOR AND OTHER DEFENSE SYSTEMS1987
- TUMOR-NECROSIS-FACTOR AS EFFECTOR MOLECULE IN MONOCYTE MEDIATED CYTOTOXICITY1986
- ROLE OF MONOCYTE CYTOTOXIC FACTOR IN CYTOLYSIS OF ACTINOMYCIN D-TREATED WEHI-164 CELLS MEDIATED BY FRESHLY ISOLATED HUMAN ADHERENT MONONUCLEAR BLOOD-CELLS1986
- Requirement for the continual presence of lipopolysaccharide for production of tumor necrosis factor by thioglycollate-induced peritoneal murine macrophagesInternational Journal of Cancer, 1986
- Tumor necrosis factor: a potent effector molecule for tumor cell killing by activated macrophages.Proceedings of the National Academy of Sciences, 1986
- Stimulation of neutrophils by tumor necrosis factor.The Journal of Immunology, 1986
- Regulation of macrophage tumor necrosis factor production by prostaglandin E2Biochemical and Biophysical Research Communications, 1986
- Recombinant Human Tumor Necrosis Factor-α: Effects on Proliferation of Normal and Transformed Cells in VitroScience, 1985
- Macrophage-mediated tumor cell killing: regulation of expression of cytolytic activity by prostaglandin E.The Journal of Immunology, 1981